Pemphigus Vulgaris

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2007-02-05
Clinical Trial Update: Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris [Phase 2]
A Phase 2 clinical trial evaluating dapsone as a steroid-sparing agent for Pemphigus vulgaris has been terminated.